
Goldman Sachs Group Inc expects to have all its staff back at their offices by the end of the year as major drugmakers roll out COVID-19 vaccines, Chief Executive Officer David Solomon said in an interview to Bloomberg Television on Tuesday.


Goldman Sachs Group Inc expects to have all its staff back at their offices by the end of the year as major drugmakers roll out COVID-19 vaccines, Chief Executive Officer David Solomon said in an interview to Bloomberg Television on Tuesday.